Vyxeos Liposomal: An overview of real-world evidence from four European studies

Key data for Vyxeos Liposomal from cohorts in England, France, Italy and Germany in the context of Study 301 results. All in a handy format you can access offline.

Prescribing Information can be found at the top of this page. Adverse event reporting is available at the bottom of this page.

Topics: Real-world Data Safety Vyxeos Liposomal Data


Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/

For Ireland, reporting forms and information can be found at: www.hpra.ie

Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com

UK-VYX-2100252 | January 2022